Related Experiment Videos

Multi drug resistant Salmonella typhi infection: clinical profile and therapy

P B Koul1, M V Murali, P P Sharma

  • 1Department of Pediatrics, University College of Medical Sciences, Delhi.

Indian Pediatrics
|April 1, 1991
PubMed

Insights

A study found that most children with enteric fever had multi-drug resistant Salmonella Typhi. These infections led to more complications, but a combination of cephalexin and gentamicin proved effective for treatment.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Enteric fever, caused by Salmonella Typhi, is a significant public health concern, particularly in pediatric populations.
  • Emergence of multi-drug resistant strains of Salmonella Typhi poses a therapeutic challenge.
  • Complications of enteric fever can be severe and life-threatening.

Purpose of the Study:

  • To investigate the prevalence of multi-drug resistant Salmonella Typhi in children with enteric fever.
  • To assess the incidence of complications associated with resistant strains.
  • To evaluate the efficacy of a combination antibiotic regimen in managing these infections.

Main Methods:

  • Retrospective analysis of 48 pediatric cases with bacteriologically confirmed enteric fever.
  • Identification of Salmonella Typhi isolates and assessment of their antibiotic resistance patterns.
  • Clinical data review for complications and treatment outcomes.

Main Results:

  • Multi-drug resistant Salmonella Typhi was identified in 35 out of 48 (72.9%) pediatric cases.
  • Higher incidence of severe complications including shock, myocarditis, encephalopathy, and paralytic ileus observed in children with resistant infections.
  • Successful management achieved using a combination of cephalexin and gentamicin.

Conclusions:

  • Multi-drug resistance in Salmonella Typhi is highly prevalent in pediatric enteric fever cases.
  • Resistant strains are associated with increased risk of severe complications.
  • Combination therapy with cephalexin and gentamicin offers a viable treatment option for drug-resistant Salmonella Typhi infections.

Related Concept Videos